[HTML][HTML] N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis

…, NF Ma, X Guan, JP Yun, FW Wang, RH Xu… - Nature …, 2019 - nature.com
Circular RNAs (circRNAs) have been implicated in cancer progression through largely
unknown mechanisms. Herein, we identify an N 6 -methyladenosine (m 6 A) modified circRNA, …

Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma

R Xu, W Wei, M Krawczyk, W Wang, H Luo, K Flagg… - Nature materials, 2017 - nature.com
An effective blood-based method for the diagnosis and prognosis of hepatocellular carcinoma
(HCC) has not yet been developed. Circulating tumour DNA (ctDNA) carrying cancer-…

[HTML][HTML] Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression

…, D Xie, W Jia, MS Zeng, W Tan, R Chen, RH Xu… - Nature …, 2019 - nature.com
N 6 -methyladenosine (m 6 A) modification is an important mechanism in miRNA processing
and maturation, but the role of its aberrant regulation in human diseases remained unclear. …

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

RM Feng, YN Zong, SM Cao, RH Xu - Cancer communications, 2019 - Wiley Online Library
Cancer is the leading cause of death in China and depicting the cancer pattern of China
would provide basic knowhows on how to tackle it more effectively. In this study we have …

[HTML][HTML] Circular RNA: metabolism, functions and interactions with proteins

WY Zhou, ZR Cai, J Liu, DS Wang, HQ Ju, RH Xu - Molecular cancer, 2020 - Springer
Circular RNAs (CircRNAs) are single-stranded, covalently closed RNA molecules that are
ubiquitous across species ranging from viruses to mammals. Important advances have been …

Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia

R Xu, H Pelicano, Y Zhou, JS Carew, L Feng… - Cancer research, 2005 - AACR
Cancer cells generally exhibit increased glycolysis for ATP generation (the Warburg effect)
due in part to mitochondrial respiration injury and hypoxia, which are frequently associated …

Effect of camrelizumab vs placebo added to chemotherapy on survival and progression-free survival in patients with advanced or metastatic esophageal squamous …

…, Y Cheng, D Wang, Y Shen, Q Yang, J Zou, RH Xu… - Jama, 2021 - jamanetwork.com
Importance Standard first-line therapy for advanced or metastatic esophageal carcinoma is
chemotherapy, but the prognosis remains poor. Camrelizumab (an anti–programmed death …

LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer

YT Tan, JF Lin, T Li, JJ Li, RH Xu… - Cancer …, 2021 - Wiley Online Library
Altered metabolism is a hallmark of cancer, and the reprogramming of energy metabolism
has historically been considered a general phenomenon of tumors. It is well recognized that …

[PDF][PDF] Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

…, Z Chen, D Jiang, Q Lin, W Ren, J Wang, L Wu, Y Xu… - Cancer cell, 2022 - cell.com
Platinum-based chemotherapy is the standard first-line treatment for advanced esophageal
squamous cell carcinoma (ESCC). In this phase 3 study (ClinicalTrial.gov: NCT03829969), …

Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

…, C Hu, K Yang, J Wen, J Li, YR Shi, F Jin, R Xu… - Nature medicine, 2021 - nature.com
Gemcitabine-cisplatin (GP) chemotherapy is the standard first-line systemic treatment for
recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). In this international, double-blind…